BIO-TECHNE Corp (TECH) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for BIO-TECHNE Corp (TECH): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 57/100 — a percentile rank of BIO-TECHNE Corp’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.
| Market cap | $11.4B |
| P / E | 62.4× |
| P / S | 9.3× |
| EV / EBITDA | 32.3× |
| Gross margin | 65.8% |
| Operating margin | 20.7% |
| Net margin | 15.0% |
| Return on equity | 8.6% |
| ROIC | 9.3% |
| Revenue growth | -0.4% |
| Debt / equity | 0.1× |
| Dividend yield | 0.4% |
Is BIO-TECHNE Corp overvalued? P/E looks fair vs its 5-year range; P/S looks fair vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks fair vs its 5-year range.
Independent of the events above — derived from BIO-TECHNE Corp’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact